Be Part of the Only Event that Unites Women Leaders in Life Sciences Law for Candid Discussion, Valuable Collaboration and Meaningful Networking
CONFERENCE CO-CHAIRS
Monique Hunt-McWilliams
Assistant General Counsel
Eli Lilly & Company
Deborah Logan
Associate General Counsel
EMD Serono
Keynote Speaker
Dr. Julie Gerberding
Executive Vice President & Chief Patient Officer
Merck
Former Director, CDC
Featured Speakers
Debbie Walters
Vice President & Assistant General Counsel
Pfizer
Shannon Thyme Klinger
Chief Legal Officer
Novartis
Sarah Heineman
Senior Counsel, Litigation
Bayer
Laurie Hill
Vice President, Intellectual Property
Genentech
Gloria Fuentes
Vice President & Assistant General Counsel
Bristol Myers Squibb
Alane Barnes
Chief Legal Officer
BioCryst Pharmaceuticals
This Year’s Highlights
- Interactive Think-Tank: How Can We Work Together to Restore and Boost Female Workforce Momentum in the Wake of the Covid-19 Pandemic
- Getting Hired and Getting Noticed in a Virtual World: Tips and Tools for Interviewing, Onboarding and Moving Up the Ranks in a Virtual Environment
- Empowering Female Colleagues Across Generational Differences: How Can We Manage and Capitalize on Generational Diversity in the Workplace
- Knowing Your Worth, And Then Asking For It: How to Effectively Negotiate Salaries While Leaving Your Emotions at the Door
- The Good, the Bad and the Ugly of Remote Work: Learning to Set Boundaries and Achieve Professional and Personal Balance in a Work-From-Home World
CLE/DIVERSITY ACCREDITATION
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as nontransitional for the purposes of CLE accreditation.
LEARN MOREGROUP PROMOTION
WHAT TO EXPECT AT OUR NEW VIRTUAL CONFERENCE
Enjoy an Easy to Use, Dynamic Online Platform
Immerse Yourself in Live Presentations and Panel Discussions
Engage with Attendees and Speakers in an Interactive Format
Meet 1-on-1 with Your Fellow Attendees
PAST ATTENDING COMPANIES
- Abbott Laboratories
- AbbVie
- Acorda Therapeutics Inc
- Akebia Therapeutics
- Alexion Pharmaceuticals Inc
- Alkermes
- Allergan
- Alnylam Pharmaceuticals
- Alvogen Inc
- Amgen Inc
- Amneal Pharmaceuticals LLC
- Analysis Group Inc
- Aptevo Therapeutics
- Arent Fox LLP
- Astellas Pharma Inc
- Axinn Veltrop & Harkrider LLP
- Axiom Law
- Bain Capital
- Bates White
- Bayer Corp
- Beam Therapeutics
- Beck Redden LLP
- Berkeley Research Group LLC
- Berkley Life Sciences LLC
- Bernstein Shur
- Bill & Melinda Gates Medical Research Institute
- Biogen
- Blake Cassels & Graydon LLP
- Boston Biomedical
- Bowman and Brooke LLP
- Brattle Group
- Bristol Myers Squibb
- Broad Institute
- Buchanan Ingersoll & Rooney PC
- Butler Snow LLP
- Cantor Colburn LLP
- Casebia Therapeutics
- Celgene Corporation
- Choate Hall & Stewart LLP
- Clark Hill Strasburger & Price
- Collegium Pharmaceutical Inc
- Contracts Associates Inc
- Cooley LLP
- Cornerstone Research
- CRISPR Therapeutics
- Crowell & Moring LLP
- Dana Farber Cancer Institute
- Davis Wright Tremaine LLP
- Debevoise & Plimpton LLP
- Dechert LLP
- Deloitte Services LP
- Department of Justice
- Desmarais LLP
- DLA Piper LLP
- Dorsey & Whitney LLP
- Duane Morris LLP
- Eisai Inc
- Eli Lilly & Company
- Emd Serono
- Entera Bio
- Epstein Becker Green
- Exponent Inc
- Faber Daeufer & Itrato PC
- Ferring Pharmaceuticals
- Finnegan Henderson Farabow Garrett & Dunner LLP
- Foley & Lardner LLP
- Forma Therapeutics Inc
- Fortress Investment Group LLC
- Foundation Medicine
- Genentech Inc
- GlaxoSmithKline
- Goldfinch Bio Inc
- Green Griffith & Borg-Breen LLP
- Greenberg Traurig LLP
- Hercules Pharmaceuticals Inc
- Honigman LLP
- Hyman Phelps & McNamara PC
- Incyte Corporation
- Intuitive Surgical
- JAMS
- Kilburn & Strode LLP
- King & Spalding LLP
- Kirkland & Ellis LLP
- Knobbe Martens Olson & Bear LLP
- Kymera Therapeutics
- Latham & Watkins LLP
- Licks Attorneys
- Loeb & Loeb LLP
- Maslon LLP
- MassBio
- Merck
- Millendo Therapeutics Inc
- Mindee Wasserman, JD CFP
- Mintz Levin Cohn Ferris Glovsky & Popeo PC
- Moderna Therapeutics Inc
- Momenta Pharmaceuticals Inc
- Morrison & Foerster LLP
- MultiMed Billing Service
- NERA Economic Consulting
- Nestle Health Science
- Nexthink
- Nexus Pharmaceuticals Inc
- Norton Rose Fulbright
- Oblon McClelland Maier & Neustadt LLP
- Office of Rupa Cornell
- OLYMPUS
- O’Melveny & Myers LLP
- Otsuka Pharmaceutical
- Pacira Pharmaceuticals Inc
- Par Pharmaceutical Inc
- Patent Trial and Appeal Board
- Paul Hastings LLP
- Paul Weiss Rifkind Wharton & Garrison LLP
- PayByPhone Technologies
- Pearl Cohen Zedek Latzer Baratz
- Pepper Hamilton LLP
- Perkins Coie LLP
- Pfizer Inc
- Phillips Lytle LLP
- PhRMA
- Pierce Atwood LLP
- Polsinelli
- PwC
- Radius Health Inc
- Reed Smith LLP
- RegenxBio
- Revance Therapeutics Inc
- Reynolds Porter Chamberlain LLP
- Ropes & Gray LLP
- Sage Therapeutics Inc
- Selecta Biosciences Inc
- Sidley Austin LLP
- Skadden Arps Slate Meagher & Flom LLP
- Smart & Biggar
- Sobi Inc
- Sopra Legal
- Special Counsel
- Steptoe & Johnson LLP
- Stoke Therapeutics
- Stuart TenHoor Legal Search
- Sunovion Pharmaceuticals Inc
- Surface Oncology Inc
- Takeda
- Thompson Coburn LLP
- Tmunity Therapeutics Inc
- Troutman Pepper
- US Attorney’s Office – District of Massachusetts
- US Food & Drug Administration
- Venable LLP
- Vertex Pharmaceuticals
- W. L. Gore & Associates Inc
- Wiggin & Dana LLP
- Winston & Strawn LLP
- Womble Bond Dickinson US LLP
ABOUT THIS CONFERENCE
This unique conference allows women attorneys and executives for the life sciences industry to discuss professional challenges and opportunities as well as foster communication between like-minded individuals about key legal developments for pharmaceutical, biotech, and medical device companies.
Join us to participate in sessions delivered by a truly remarkable group of senior level women life sciences legal executives for substantive legal updates as well as great networking and mentoring opportunities.
OUR MISSION
This conference brings together in house and private practice professionals from the Pharmaceutical, Biotechnology, and Medical Device industries, well-versed in patents, IP, fraud and abuse compliance/enforcement, products liability, regulatory, M&A, and transactional law, and more providing most conducive setting for networking and career development between female legal, business, and compliance professionals.
OUR PROMISE
ACI’s Women Leaders in Law Series aims to promote diversity and increase the prominence of women in the legal community through substantive legal discussion, professional development, and woman-to-woman networking. Our conferences provide industry specific forums for female powerbrokers to unite and discuss the substantive legal developments, challenges and opportunities facing women in their respective industries as well as provide them with the business contacts and communication and leadership skills necessary for continued success and career advancement.
RECORDED EVENTS
2020 Conference Recording
Missed last year’s conference? Watch a recording of the 7th annual event.
PURCHASE RECORDINGWebinar Recording
How COVID-19 is Transforming the Workplace: Insights on “Return to Work,” Adapting to the “New Normal” and More
FREE DOWNLOADTESTIMONIALS
If law firms and law departments are serious about developing women leaders, then they’ll send them to this conference. The who’s who of health care lawyers are here and there are multiple opportunities for informal networking and mentoring conversations.
This conference is one of the few events I have attended that is focused on women helping women with real-life, practical tips on how to make a significant impact on your career. Many of the speakers are willing to share stories not just of success, but stories of adversity and how to turn those situations around into successful ones. I block my calendar early, so I can be sure to attend each year.
GLOBAL SERIES OF LIFE SCIENCES
The Women Leaders in Life Sciences Law conference is part of a group of life sciences conferences that cover every facet of legal and business relevance as well as controversy.
Learn More
